FDA lifts 14-year ban on silicone-gel breast implants

Washington, DC — The Food and Drug Administration has ended a 14-year ban on the sale of silicone-gel breast implants, to the pleasure of the two remaining manufacturers of the devices and the consternation of women’s health advocates.

After years of clinical trials and other studies, the FDA has found no convincing evidence linking silicone gel with cancer or connective tissue disease in women, said Daniel Schultz, director of the FDA’s Center for Devices and Radiological Health.

However, the two implant makers, Mentor Corp. and Allergan Corp.,…

To read more,please login or register below.

This is the first step to more free
content, user offers, subscriptions
and more.
Log in here using the Email Address
and Password you signed up with